Anzeige
Mehr »
Login
Mittwoch, 06.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus“ in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CPQ7 | ISIN: US65342V1017 | Ticker-Symbol:
NASDAQ
06.11.24
20:36 Uhr
15,830 US-Dollar
+0,660
+4,35 %
1-Jahres-Chart
NEXPOINT REAL ESTATE FINANCE INC Chart 1 Jahr
5-Tage-Chart
NEXPOINT REAL ESTATE FINANCE INC 5-Tage-Chart
PR Newswire
60 Leser
Artikel bewerten:
(0)

NexPoint Real Estate Finance, Inc.: NREF Announces Third Quarter 2024 Results, Provides Fourth Quarter 2024 Guidance

DALLAS, Oct. 31, 2024 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended September 30, 2024.

NREF reported net income attributable to common stockholders of $16.1 million, or $0.75 per diluted share1, for the three months ended September 30, 2024.

NREF reported cash available for distribution2 of $15.8 million, or $0.67 per diluted common share2, for the three months ended September 30, 2024.

"NREF is pleased to report another strong quarter, showcasing consistent and resilient earnings across our core property types. Amidst a landscape where banks and traditional lenders are often sidelined or preoccupied with credit issues, we remain active and focused. Our readiness to deploy capital in this challenging credit market allows us to capitalize on market dislocations and create long-term value for our shareholders," commented Chief Investment Officer Matthew McGraner.

Third Quarter 2024 Highlights

  • Outstanding total portfolio of $1.1 billion, composed of 83 investments3
  • Single-family rental ("SFR"), multifamily, life sciences and specialty manufacturing, self-storage and marinas represent 17.0%, 52.3%, 26.7%, 1.5% and 0.6% of the Company's investment portfolio, respectively
  • Weighted-average loan to value ("LTV")4 and debt service coverage ratio ("DSCR") on our SFR, CMBS, CMBS I/O strips, preferred equity, mezzanine, credit risk transfer and mortgage-backed security investments are 60.2% and 1.36x3, respectively
  • As of October 31, 2024, there are no loans currently in forbearance in our portfolio
  • During 3Q 2024, NREF sold a CMBS B-Piece with an outstanding principal balance of $82.0MM with bond equivalent yield of 9.20%
  • During the quarter, the Company funded $28.8MM on a loan that pays a monthly coupon of SOFR + 900 bps.

1 Weighted-average shares outstanding - diluted assumes vesting of all outstanding unvested restricted stock units and the conversion of all redeemable non-controlling interests.

2 Earnings available for distribution ("EAD") and cash available for distribution ("CAD") are non-GAAP measures. Beginning in the second quarter of 2024, EAD per diluted common share and CAD per diluted common share are based on adjusted weighted average common shares outstanding - diluted. Adjusted weighted average common shares outstanding - diluted is a non-GAAP measure. For a discussion of why we consider these non-GAAP measures useful and reconciliations of these non-GAAP measures, see the "Reconciliations of Non-GAAP Financial Measures" and "Non-GAAP Financial Measures" sections of this release.

3 As of September 30, 2024; and excluding the common stock investments, preferred stock investment, the Hudson Montford and Alexander at the District multifamily properties. CMBS B-Pieces reflected on an unconsolidated basis.

4 Loan to value is generally based on the initial loan amount divided by the as-is appraised value as of the date the loan was originated or by the current principal amount as of the date of the most recent as-is appraised value. For our CMBS B-Pieces, LTV is based on the weighted-average LTV of the underlying loan pool.

5 Net income attributable to common stockholders in 4Q 2024 is estimated to be between $16.1MM and $18.4MM. See reconciliations below.

Looking Ahead: Fourth Quarter 2024 Guidance

Earnings Available for Distribution2

  • 4Q 2024 EAD per diluted common share guidance is $0.79 5 at the midpoint


Low



Mid



High




Dec. 31, 2024



Dec. 31, 2024



Dec. 31, 2024


Net income


$

20,074



$

21,131



$

22,399


Net (income) loss attributable to Series A Preferred stockholders



(874)




(874)




(874)


Net (income) loss attributable to Series B Preferred stockholders



(3,106)




(3,106)




(3,106)


Net income attributable to common stockholders


$

16,094



$

17,151



$

18,419


Adjustments













Amortization of stock-based compensation



1,411




1,411




1,411


EAD


$

17,505



$

18,562



$

19,830















Weighted average common shares outstanding - basic



17,461




17,461




17,461


Weighted average common shares outstanding - diluted



31,317




31,317




31,317


Shares attributable to potential redemption of Series B Preferred



(7,897)




(7,897)




(7,897)


Adjusted weighted average common shares outstanding - diluted



23,420




23,420




23,420















EPS per Weighted Average Share - diluted


$

0.61



$

0.65



$

0.69


EAD per diluted common share


$

0.75



$

0.79



$

0.85















EPS Dividend Coverage Ratio



1.22

x



1.30

x



1.38

x

EAD Dividend Coverage Ratio



1.50

x



1.58

x



1.70

x

Cash Available for Distribution2

  • 4Q 2024 CAD per diluted common share guidance is $0.50 5 at the midpoint


Low



Mid



High




Dec. 31, 2024



Dec. 31, 2024



Dec. 31, 2024


EAD


$

17,505




18,562



$

19,830


Adjustments













Amortization of premiums



2,071




2,071




2,071


Accretion of discounts



(10,041)




(10,041)




(10,041)


Amortization and depreciation



1,079




1,079




1,079


CAD


$

10,614



$

11,671



$

12,939















Weighted average common shares outstanding - basic



17,461




17,461




17,461


Weighted average common shares outstanding - diluted



31,317




31,317




31,317


Shares attributable to potential redemption of Series B Preferred



(7,897)




(7,897)




(7,897)


Adjusted weighted average common shares outstanding - diluted



23,420




23,420




23,420















EPS per Weighted Average Share - diluted


$

0.61



$

0.65



$

0.69


CAD per diluted common share


$

0.45



$

0.50



$

0.55















EPS Dividend Coverage Ratio



1.22

x



1.30

x



1.38

x

CAD Dividend Coverage Ratio



0.90

x



1.00

x



1.10

x

Conference Call Details
The Company is scheduled to host a conference call on Thursday, October 31, 2024, at 11:00 a.m. ET (10:00 a.m. CT), to discuss third quarter 2024 financial results.

The conference call can be accessed live over the phone by dialing 888-660-4430 or +1 646-960-0537 and entering Conference ID 6891136. A live audio webcast of the call will be available online at the Company's website, https://nref.nexpoint.com (under "Resources"). An online replay will be available shortly after the call on the Company's website and continue to be available for 60 days.

A replay of the conference call will also be available through Thursday, November 14, 2024, by dialing 1 800- 770- 2030 or, for international callers, +1 647- 362- 9199 and entering passcode 6891136.

For additional commentary and portfolio information, please view NREF's earning supplement, which was posted on the Company's website, http://nref.nexpoint.com.

Reconciliations of Non-GAAP Financial Measures
The following table provides a reconciliation of Earnings Available for Distribution2 and Cash Available for Distribution2 to GAAP net income attributable to common stockholders and Adjusted Weighted Average Common Shares Outstanding - diluted to Weighted Average Common Shares Outstanding - diluted (in thousands, except per share amounts):



For the Three Months Ended September 30,




2024



2023


Net income (loss) attributable to common stockholders


$

16,116




(15,550)


Net income attributable to redeemable noncontrolling interests



3,940




(2,374)


Adjustments









Amortization of stock-based compensation



1,411




1,285


Provision for (reversal of) credit losses



(298)




6,276


Equity in (income) losses of equity method investments (1)



1,105




1,675


Unrealized (gains) or losses (2)



(4,660)




18,508


EAD


$

17,614



$

9,820











EAD per diluted common share (3)


$

0.75



$

0.43











Adjustments









Amortization of premiums


$

4,093




3,530


Accretion of discounts



(7,071)




(3,038)


Depreciation and amortization of real estate investments



1,099




476


Amortization of deferred financing costs



12




(26)


CAD


$

15,747



$

10,762











CAD per diluted common share


$

0.67



$

0.47











Weighted-average common shares outstanding - basic



17,461




17,232


Weighted-average common shares outstanding - diluted



30,468




23,086


Shares attributable to potential redemption of Series B Preferred



7,048




-


Adjusted weighted-average common shares outstanding - diluted



23,420




23,086




(1)

Starting in the third quarter of 2023, the Company has adjusted EAD to remove the (income) / loss from equity method investments as it does not represent distributable earnings. We will include income from equity method investments to the extent that we receive cash distributions and upon realizing gains and/or losses.

(2)

Unrealized gains represent the net change in unrealized gains on investments held at fair value.

(3)

Beginning in the second quarter of 2024, EAD per diluted common share and CAD per diluted common share are based on adjusted weighted average common shares outstanding - diluted.

About NexPoint Real Estate Finance, Inc.

NexPoint Real Estate Finance, Inc., is a publicly traded REIT, with its common stock and 8.50% Series A Cumulative Redeemable Preferred Stock listed on the New York Stock Exchange, primarily focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties and common equity investments, as well as multifamily and single-family commercial mortgage-backed securities securitizations, promissory notes and mortgage-backed securities. More information about the Company is available at http://nref.nexpoint.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's current expectations, assumptions and beliefs. Forward-looking statements can often be identified by words such as "anticipate", "believe," "estimate", "expect," "intend," "may", "should" and similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding the Company's business, strategy and industry in general, fourth quarter 2024 guidance, including net income, net income attributable to common stockholders, EAD, CAD, EAD and CAD per diluted common share and related coverage ratios, assumptions and estimates and the Company's intent to not settle Series B Preferred redemptions in shares of common stock when the Company's common stock price is below book value. They are not guarantees of future results and forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statement, including those described in greater detail in our filings with the Securities and Exchange Commission (the "SEC"), particularly those described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company's Annual Report on Form 10-K and the Company's other filings with the SEC for a more complete discussion of risks and other factors that could affect any forward-looking statement. The statements made herein speak only as of the date of this press release and except as required by law, the Company does not undertake any obligation to publicly update or revise any forward-looking statements.

Non-GAAP Financial Measures

This press release contains non-GAAP financial measures. A "non-GAAP financial measure" is defined as a numerical measure of a company's financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP in the statements of income, balance sheets or statements of cash flows of the Company. The non-GAAP financial measures used within this press release are EAD, CAD, EAD and CAD per diluted common share and adjusted weighted average common shares outstanding - diluted.

EAD is defined as net income (loss) attributable to our common stockholders computed in accordance with GAAP, including realized gains and losses not otherwise included in net income (loss), excluding any unrealized gains or losses or other similar non-cash items that are included in net income (loss) for the applicable reporting period, regardless of whether such items are included in other comprehensive income (loss), or in net income (loss) and adding back amortization of stock-based compensation. Net income (loss) attributable to common stockholders may also be adjusted for the effects of certain GAAP adjustments and transactions that may not be indicative of our current operations. In addition, EAD in this press release includes the dilutive effect of non-controlling interests. We use EAD to evaluate our performance and to assess our long-term ability to pay distributions. We believe providing EAD as a supplement to GAAP net income (loss) to our investors is helpful to their assessment of our performance and our long-term ability to pay distributions. We also use EAD as a component of the management fee paid to our external manager. EAD does not represent net income or cash flows from operating activities and should not be considered as an alternative to GAAP net income, an indication of our GAAP cash flows from operating activities, a measure of our liquidity or an indication of funds available for our cash needs. Our computation of EAD may not be comparable to EAD reported by other REITs. Starting in the third quarter of 2023, the Company has adjusted EAD to remove the income/(losses) from equity method investments as they represent changes in the equity value of our investment rather than distributable earnings. The Company will include income from equity method investments to the extent that we receive cash distributions and upon realizing gains and/or losses.

We calculate CAD by adjusting EAD by adding back amortization of premiums, depreciation and amortization of real estate investment and amortization of deferred financing costs and by removing accretion of discounts. We use CAD to evaluate our performance and our current ability to pay distributions. We also believe that providing CAD as a supplement to GAAP net income (loss) to our investors is helpful to their assessment of our performance and our current ability to pay distributions. CAD does not represent net income or cash flows from operating activities and should not be considered as an alternative to GAAP net income, an indication of our GAAP cash flows from operating activities, a measure of our liquidity or an indication of funds available for our cash needs. Our computation of CAD may not be comparable to CAD reported by other REITs.

Adjusted weighted average common shares outstanding - diluted is calculating by subtracting the dilutive effect of potential redemptions of Series B Preferred shares for shares of our common stock from weighted average common shares outstanding - diluted. We believe providing adjusted weighted average common shares outstanding - diluted to our investors is helpful in their assessment of our performance without the potential dilutive effective of the Series B Preferred shares. We have the right to redeem the Series B Preferred shares for cash or shares of our common stock. Additionally, Series B Preferred redemptions are capped at 2% of the outstanding Series B Preferred shares per month, 5% per quarter and 20% per year. The Company maintains sufficient liquidity to pay cash to cover any redemptions up to the quarterly redemption cap. Further, it is the Company's intent to not settle Series B Preferred redemptions in shares of common stock when the Company's common stock price is below book value.

Adjusted weighted average common shares outstanding - diluted should not be considered as an alternative to the GAAP measure. Our computation of adjusted weighted average common shares outstanding - diluted may not be comparable to adjusted weighted average common shares outstanding - diluted reported by other companies.

Contact:
Kristen Griffith
Investor Relations
[email protected]
Media: [email protected]

SOURCE NexPoint Real Estate Finance, Inc.

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.